biote Corp.

BioTE Corp (Nasdaq: BTMD) is a hormone health company that completed its business combination with Haymaker Acquisition Corp. III, a blank-check vehicle sponsored by Haymaker Sponsor III, LLC, with the merger closing in May 2022. The SPAC had priced its IPO in 2021, targeting the healthcare and wellness sector. BioTE operates a practitioner-facing hormone pellet therapy platform, partnering with licensed healthcare providers across the United States to deliver bioidentical hormone replacement therapy services and training. The company filed its 10-K with the SEC on April 7, 2022, reflecting its earliest period as a publicly traded entity. For full filing history, shareholder data, and deal analytics on BTMD, sign up for complete access at SpacDesk.